PWS
ABBV icon

Precision Wealth Strategies’s AbbVie ABBV Stock Holding History

Precision Wealth Strategies’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,363
Closed -$543K – 74
2022
Q4 		$543K Sell
3,363
-15
-0.4% -$2.3K 0.57% 31
2022
Q3 		$510K Buy
3,378
+114
+3% +$16.4K 0.45% 45
2022
Q2 		$497K Buy
3,264
+178
+6% +$27.2K 0.39% 50
2022
Q1 		$500K Sell
3,086
-1,424
-32% -$207K 0.3% 71
2021
Q4 		$611K Buy
4,510
+647
+17% +$76.4K 0.44% 67
2021
Q3 		$417K Buy
3,863
+1,812
+88% +$207K 0.32% 75
2021
Q2 		$231K Buy
+2,051
New +$231K 0.2% 97

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Precision Wealth Strategies's ABBV Position: Q1 2023 in Review

Precision Wealth Strategies sold out of AbbVie (ABBV) in Q1 2023, closing a stake of 3,363 shares — an estimated $543K sold.

Precision Wealth Strategies first reported a position in ABBV in Q2 2021 and held it in 7 quarters. The position peaked at $611K in Q4 2021. 3,139 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

  • Precision Wealth Strategies reported no remaining AbbVie position as of Q1 2023 after selling out during the quarter.
  • Precision Wealth Strategies sold 3,363 AbbVie shares in Q1 2023, an estimated $543K.
  • Precision Wealth Strategies first reported a position in AbbVie in Q2 2021 and held it in 7 quarters.
  • Precision Wealth Strategies's AbbVie position peaked at $611K in Q4 2021.
  • 3,139 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on Precision Wealth Strategies's 13F filing for Q1 2023, filed 4 May 2023.